Open access
Oct 2026
The Smac mimetic drug Xevinapant sensitizes triple negative breast cancer to radiotherapy-induced cell death in a TNFα dependent manner
M. Faye, J. Lafontaine, P. Wong et al.
· bioRxiv · 0 citations